Oncomine Dx Target Test returns results in days, helping physicians rapidly develop treatment plans for the most common form of lung cancer CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific for the first next-generation sequencing (NGS)-based test  that simultaneously screens tumor samples for biomarkers associated with […]

AMSBIO has introduced a range of purified cancer exosome samples to help researchers study the role of exosomes in cancer development and metastasis. By targeted filtration of patient serum using a specific binding method removes protein contaminant to isolate exosome at 95% high purity. Using this proprietary filtration method, the purified tumor exosome does not […]

Etaluma and DRVision Ink Partnership on Combining Lumascope (LS Microscope) Live Cell Imaging with Aivia Image Visualization and Analysis (Carlsbad, CA) Today Etaluma and DRVision announced a strategic partnership that combines the power of imaging by Etaluma’s next generation inverted LS microscopes (Lumascopes) and DRVision’s innovative image visualization, analysis and data exploration technology called Aivia. […]

Budapest, Hungary – University of Debrecen (UD), Hungary and BGI Group signed a Memorandum of Understanding, Tuesday 20th June, regarding cooperation on the establishment of a local NGS sequencing hub for local population cohort studies and diagnostic testing, and wider collaboration in the research and development of genetic and genomic sciences. The MOU was signed […]

San Diego-based cell culture products supplier announces new, larger headquarters as sales of its Australian origin, fully traceable and characterized fetal bovine serum continues to climb SAN DIEGO – Nucleus Biologics, a premium cell culture products supplier to the biotech and pharmaceutical industries, is announcing it has recently moved to a new 10,511 square foot office […]

LONDON, ON – 3M announced today that Health Canada has approved and published the next-generation 3M Molecular Detection System assay for Listeria detection. Based on isothermal DNA amplification and bioluminescence detection – the same combination of advanced technologies used in all 3M Molecular Detection Assays – these assays use new chemistry to deliver accurate results with shorter […]

HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), today announced the launch of ddPCR™ Genome Edit Detection Assays, the first tests to characterize edits generated by CRISPR-Cas9 or other genome editing tools using Bio-Rad’s Droplet Digital PCR (ddPCR) technology. Users can specify their sequences and order assays through Bio-Rad’s Digital Assay Site. Successful genome editing is […]

Commercial agreement with Congenica supports UniteGen’s goal of achieving the world’s largest human genome database Cambridge, UK – Congenica’s Sapientia™ clinical genome analysis software platform will be used by China-based UniteGen to carry out whole genome sequencing (WGS) processing and analysis as part of China’s “100K Wellness Pioneer Project”, hosted by Beijing 4P Health Research […]

Customized TR-FRET immunoassay kit development services fast-track new product development SAN DIEGO—-BioAuxilium Research Inc., a Canadian biotech specialized in the development of custom TR-FRET assay kits, announced today at the 2017 BIO International Convention the successful development of its 100th custom TR-FRET immunoassay kit. These easy-to-use, fully validated assay kits provide researchers with homogeneous, robust […]

SANTA BARBARA, Calif. — SerImmune Inc. today announced an $8 million round of financing, led by Illumina Ventures, with participation from Merck, known as MSD outside the United States and Canada, through a subsidiary, and additional undisclosed investors. With the proceeds, SerImmune will expand its immune mapping technology platform and antibody repertoire database while building strategic […]